By API User
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–BUSINESS WIRE– Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an … Continued
By API User
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on … Continued
By API User
DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time … Continued
By API User
A team of scientists from Monash University has identified a single gene in a land plant that could help explain how plants first evolved the ability to grow continuously, a key trait that allowed them to colonise dry land and shape life on Earth. Published in Current Biology, the study focuses on Marchantia polymorpha, a liverwort … Continued
By API User
A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a second hip fracture, subsequent fractures, and death in people prescribed two different classes of bone strengthening medications. The researchers conducted a series of parallel population-based cohort studies in Australia, Hong Kong, … Continued
By API User
Open letter to the Victorian Premier, Treasurer, and Health Minister (Issued by the Public Health Association of Australia on the authors’ behalf). 8 December 2025 As five former Chairs of VicHealth, representing a broad political spectrum and different eras of VicHealth’s work, we write to ask you to reconsider your Government’s decision to … Continued
By API User
A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia by Monash Health and the School of Clinical Sciences at Monash University. The PISCES trial involved 1,228 participants across 26 dialysis sites … Continued
By API User
Key Facts: UNSW researchers are turning what was once waste into a protective film that could help extend the expiry date of some of Australia’s favourite summer fruits. Ever splurged on a punnet (or few) of blueberries only to find them a wrinkled, grey-flecked disappointment in your fridge a few days later? You’re not alone. … Continued
By API User
Key Facts: Life expectancy for Australians living with DMD have increased from 18 for those borne before 1970, to around 30 today. As adult care remains fragmented and inconsistent between hospitals and States, the Symposium will develop global multi-disciplinary care recommendations. MEDIA RELEASE A world-first International Symposium dedicated to improving multi-disciplinary clinical care for adults living … Continued
By API User
VIENNA–BUSINESS WIRE– AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new … Continued
